ACADIA Pharmaceuticals
Committed to developing treatments for neurological disorders.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | $288m | Post IPO Equity |
| Total Funding | 000k | ||
Oxford Bioscience Partners(exited)
OrbiMed(exited)
LD Pensions(exited)
Forbion Capital Partners(exited)
Federated Hermes(exited)
Nomura(exited)
Venrock(exited)
NEA(exited)
Nordic Biotech(exited)
New Leaf Venture Partners(exited)
BankInvest(exited)
LD Pensions(exited)
DKA Capital(exited)
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 10 % | 7 % | 40 % | 32 % | 11 % | 11 % | 13 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (35 %) | (43 %) | (9 %) | (5 %) | 8 % | 14 % | 26 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (35 %) | (42 %) | (8 %) | 24 % | 8 % | 13 % | 21 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 49 % | 70 % | 48 % | 32 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by ACADIA Pharmaceuticals
Edit
ACQUISITION by ACADIA Pharmaceuticals Aug 2020